Home » Topics » BioWorld Science

BioWorld Science
RSS

Epigenetic inactivation of CELF2 associated with shorter overall survival in breast cancer

Sep. 9, 2019

GlaxoSmithKline presents the discovery of GSK-778

Sep. 9, 2019

Discovery of novel HCV inhibitor L-0909

Sep. 9, 2019

China's NMPA approves Focus V for third-line treatment of SCLC

Sep. 6, 2019

European Commission approves Lonsurf for metastatic gastric cancer

Sep. 6, 2019

Universite de Liege discovers new antibacterials

Sep. 6, 2019

Adlai Nortye discloses adenosine A2A and/or A2B receptor antagonists

Sep. 6, 2019

Sinovent presents new E-NPP 2 inhibitors

Sep. 6, 2019

European Commission approves Tecentriq for extensive-stage SCLC and non-squamous NSCLC

Sep. 6, 2019

Merck & Co. describes HIV integrase inhibitors

Sep. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...